[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003270518A8 - Therapeutic anti-bgp(c-cam1) antibodies and uses thereof - Google Patents

Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Info

Publication number
AU2003270518A8
AU2003270518A8 AU2003270518A AU2003270518A AU2003270518A8 AU 2003270518 A8 AU2003270518 A8 AU 2003270518A8 AU 2003270518 A AU2003270518 A AU 2003270518A AU 2003270518 A AU2003270518 A AU 2003270518A AU 2003270518 A8 AU2003270518 A8 AU 2003270518A8
Authority
AU
Australia
Prior art keywords
cam1
bgp
antibodies
therapeutic anti
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270518A
Other versions
AU2003270518A1 (en
Inventor
Richard S Blumberg
Atul Bhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
General Hospital Corp
Original Assignee
Brigham and Womens Hospital Inc
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/241,369 external-priority patent/US20040047858A1/en
Priority claimed from EP20020020334 external-priority patent/EP1400535A1/en
Application filed by Brigham and Womens Hospital Inc, General Hospital Corp filed Critical Brigham and Womens Hospital Inc
Publication of AU2003270518A8 publication Critical patent/AU2003270518A8/en
Publication of AU2003270518A1 publication Critical patent/AU2003270518A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003270518A 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof Abandoned AU2003270518A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/241,369 US20040047858A1 (en) 2002-09-11 2002-09-11 Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof
EP02020334.5 2002-09-11
US10/241,369 2002-09-11
EP20020020334 EP1400535A1 (en) 2002-09-11 2002-09-11 Therapeutic anti-BGP (C-CAM1) antibodies and uses thereof
PCT/US2003/028416 WO2004024746A2 (en) 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Publications (2)

Publication Number Publication Date
AU2003270518A8 true AU2003270518A8 (en) 2004-04-30
AU2003270518A1 AU2003270518A1 (en) 2004-04-30

Family

ID=31995518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270518A Abandoned AU2003270518A1 (en) 2002-09-11 2003-09-11 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Country Status (2)

Country Link
AU (1) AU2003270518A1 (en)
WO (1) WO2004024746A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6385277B2 (en) * 2011-12-01 2018-09-05 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． Anti-CEACAM1 recombinant antibody for cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody

Also Published As

Publication number Publication date
WO2004024746A3 (en) 2004-07-29
WO2004024746A9 (en) 2004-06-10
WO2004024746A2 (en) 2004-03-25
AU2003270518A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
HK1205748A1 (en) Therapeutic epitopes and uses thereof
EP1572131A4 (en) Antibody therapy
EP1539941A4 (en) Adzymes and uses thereof
EP1699485A4 (en) Anti-hydroxylase antibodies and uses thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
IL166063A0 (en) Antibodies and uses thereof
GB0207410D0 (en) Compounds and their therapeutic use
AU2003226899A8 (en) Human diabetes-mediating proteins
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003207628A8 (en) Structural and cytoskeleton-associated proteins
AU2003231827A8 (en) Pseudo-tissues and uses thereof
IL172510A0 (en) Antibodies and uses thereof
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
EP1569928A4 (en) Therapeutic compounds and methods
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
EP1487547A4 (en) Physical interaction means and related uses thereof
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
EP1577322A4 (en) Novel proteins and use thereof
EP1541677A4 (en) Novel proteins and use thereof
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
AU2003216442A8 (en) Enkurin and uses thereof
GB0227080D0 (en) Antibodies and uses thereof
AU2003263751A8 (en) Novel proteins and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase